Literature DB >> 3097718

Inhibition of the shake response in rats by adenosine and 2-chloroadenosine.

S Y Tse, E T Wei.   

Abstract

Shaking movements, similar to those made by a dog when wet, were elicited in rats by immersion in ice-water, injections of icilin, a chemical that produces sensations of cold, and naloxone-precipitated morphine withdrawal. Adenosine and 2-chloroadenosine produced dose-dependent inhibition of shaking to ice-water and icilin. The 2-chloroadenosine effect was mediated centrally because the ICV dose required to produce inhibition was not effective when given IP. Caffeine antagonized the inhibitory effects of adenosine and 2-chloroadenosine. 2-Chloroadenosine suppressed morphine-abstinence shaking as well as the body weight loss that normally accompanies withdrawal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097718     DOI: 10.1007/bf00179184

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

2.  Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice.

Authors:  R D Gibson; J E Tingstad
Journal:  J Pharm Sci       Date:  1970-03       Impact factor: 3.534

3.  Potassium exchange between cerebrospinal fluid, plasma, and brain.

Authors:  H Cserr
Journal:  Am J Physiol       Date:  1965-12

4.  The cerebral ventricles of the rat.

Authors:  I M Levinger
Journal:  J Anat       Date:  1971-04       Impact factor: 2.610

5.  Increased insulin sensitivity in soleus muscle from cold-exposed rats: reversal by an adenosine-receptor agonist.

Authors:  L Budohoski; R A Challiss; F J Lozeman; B McManus; E A Newsholme
Journal:  FEBS Lett       Date:  1984-10-01       Impact factor: 4.124

6.  Inhibition of shaking movements in rats by central administration of cholinergic and adrenergic agents.

Authors:  E T Wei
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Interactions in the behavioral effects of methylxanthines and adenosine derivatives.

Authors:  J J Katims; Z Annau; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

8.  Hippocampal involvement in the pharmacologic induction of withdrawal-like behaviors.

Authors:  R L Isaacson; T H Lanthorn
Journal:  Fed Proc       Date:  1981-04

9.  Sedative and anticonvulsant effects of adenosine analogs in mouse and rat.

Authors:  T V Dunwiddie; T Worth
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

Review 10.  Human disposition and some biochemical aspects of methylxanthines.

Authors:  D W Yesair; A R Branfman; M M Callahan
Journal:  Prog Clin Biol Res       Date:  1984
View more
  5 in total

1.  Translating drug-induced hibernation to therapeutic hypothermia.

Authors:  Tulasi R Jinka; Velva M Combs; Kelly L Drew
Journal:  ACS Chem Neurosci       Date:  2015-04-08       Impact factor: 4.418

Review 2.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

3.  AMP-dependent hypothermia affords protection from ischemic brain injury.

Authors:  Mirko Muzzi; Francesco Blasi; Alberto Chiarugi
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-05       Impact factor: 6.200

4.  Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.

Authors:  Luigi Stella; Vito De Novellis; Maria Redenta Vitelli; Annalisa Capuano; Filomena Mazzeo; Liberato Berrino; Francesco Rossi; Amelia Filippelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-17       Impact factor: 3.000

5.  A sensory-labeled line for cold: TRPM8-expressing sensory neurons define the cellular basis for cold, cold pain, and cooling-mediated analgesia.

Authors:  Wendy M Knowlton; Radhika Palkar; Erika K Lippoldt; Daniel D McCoy; Farhan Baluch; Jessica Chen; David D McKemy
Journal:  J Neurosci       Date:  2013-02-13       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.